|
|
Taiwan Academic Institutional Repository >
Browse by Title
|
Showing items 217821-217830 of 2351361 (235137 Page(s) Totally)
<< < 21778 21779 21780 21781 21782 21783 21784 21785 21786 21787 > >>
View [10|25|50] records per page
| 臺北醫學大學 |
2002 |
AZC-5(Aziridinoquinonylcarbon-5)對DNA烷基化作用能力的研究及其對Hep-2喉癌細胞毒殺作用的探討
|
蔡欣達; Hsin-Da Tsai |
| 臺大學術典藏 |
2020-05-26T09:26:42Z |
AZD3759, a BBB-penetrating EGFR inhibitor for the treatment of EGFR mutant NSCLC with CNS metastases
|
Bai Y; Rabbie S; Kim D.-W; Ahn M.-J; CHIH-HSIN YANG; Zhang X.; Zhang X.;Chih-Hsin Yang;Ahn M.-J;Kim D.-W;Rabbie S;Bai Y;Yin X;Xu Y;Cheng Z;Zhang L;Chen K;Wang Y;Guo Q;Yang Z; Yang Z; Guo Q; Wang Y; Chen K; Zhang L; Cheng Z; Xu Y; Yin X |
| 國立臺灣大學 |
2015 |
AZD3759, an EGFR inhibitor with blood brain barrier (BBB) penetration for the treatment of non-small cell lung cancer (NSCLC) with brain metastasis (BM): Preclinical evidence and clinical cases.
|
Kim, Dong-Wan; Yang, James Chih-Hsin; Chen, Kan; Cheng, Ziqiang; Yin, Lucy; Martin, Paul David; Yang, Zhenfan; Jiang, Haiyi; Ahn, Myung-Ju; 楊志新 |
| 元智大學 |
Mar-18 |
AZD8055 exerts antitumor effects on colon cancer cells by inhibiting mTOR and cell-cycle progression
|
Yun Chen; Cheng-Hung Lee; Bor-Yuan Tseng; Ya-Hui Tsai; Huang-Wen Tsai; Chao-Ling Yao; Sheng-Hong Tseng |
| 臺大學術典藏 |
2020-03-12T08:24:31Z |
AZD8055 exerts antitumor effects on colon cancer cells by inhibiting mTOR and cell-cycle progression
|
Chen Y.; Chen Y.;Lee C.-H.;Tseng B.-Y.;Tsai Y.-H.;Tsai H.-W.;Yao C.-L.;Sheng-Hong Tseng; SHENG-HONG TSENG; Yao C.-L.; Tsai H.-W.; Tsai Y.-H.; Lee C.-H.; Tseng B.-Y. |
| 國立臺灣大學 |
2015 |
AZD9291 in EGFR Inhibitor-Resistant Non-Small-Cell Lung Cancer
|
Jaenne, Pasi A.; Yang, James Chih-Hsin; Kim, Dong-Wan; Planchard, David; Ohe, Yuichiro; Ramalingam, Suresh S.; Ahn, Myung-Ju; Kim, Sang-We; Su, Wu-Chou; Horn, Leora; Haggstrom, Daniel; Felip, Enriqueta; Kim, Joo-Hang; Frewer, Paul; Cantarini, Mireille; Brown, Kathryn H.; Dickinson, Paul A.; Ghiorghiu, Serban; Ranson, Malcolm; 楊志新 |
| 臺大學術典藏 |
2020-05-26T09:26:54Z |
AZD9291 in EGFR inhibitor-resistant non-small-cell lung cancer
|
Ranson M.;Ghiorghiu S;Dickinson P.A;Brown K.H;Cantarini M;Frewer P;Kim J.-H;Felip E;Haggstrom D;Horn L;Su W.-C;Kim S.-W;Ahn M.-J;Ramalingam S.S;Ohe Y;Planchard D;Kim D.-W;Chih-Hsin Yang;J?nne P.A; Jänne P.A; Chih-Hsin CHIH-HSIN YANG; Kim D.-W; Planchard D; Ohe Y; Ramalingam S.S; Ahn M.-J; Kim S.-W; Su W.-C; Horn L; Haggstrom D; Felip E; Kim J.-H; Frewer P; Cantarini M; Brown K.H; Dickinson P.A; Ghiorghiu S; Ranson M. |
| 國立臺灣大學 |
2015 |
AZD9291, a mutant-selective EGFR inhibitor, as first-line treatment for EGFR mutation-positive advanced non-small cell lung cancer (NSCLC): Results from a phase 1 expansion cohort.
|
Ramalingam, Suresh S.; Yang, James Chih-Hsin; Lee, Chee Khoon; Kurata, Takayasu; Kim, Dong-Wan; John, Thomas; Nogami, Naoyuki; Ohe, Yuichiro; Rukazenkov, Yuri; Frewer, Paul; Cantarini, Mireille; Ghiorghiu, Serban; Janne, Pasi A.; 楊志新 |
| 臺北醫學大學 |
2011 |
Azeic-A cream 200mggm 12gmtube 使痘消 軟膏
|
藥劑部藥師 |
| 高雄醫學大學 |
2003 |
Azelaic acid之衍生化氣相層析分析研究
|
楊嘉昌; Yang, Chia-Chang |
Showing items 217821-217830 of 2351361 (235137 Page(s) Totally)
<< < 21778 21779 21780 21781 21782 21783 21784 21785 21786 21787 > >>
View [10|25|50] records per page
|
